These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18765081)

  • 1. Adenosine A1 antagonists and the cardiorenal syndrome.
    Gottlieb SS
    Curr Heart Fail Rep; 2008 Jun; 5(2):105-9. PubMed ID: 18765081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of BG9719 (CVT-124), an A1-adenosine receptor antagonist, and furosemide on glomerular filtration rate and natriuresis in patients with congestive heart failure.
    Gottlieb SS; Skettino SL; Wolff A; Beckman E; Fisher ML; Freudenberger R; Gladwell T; Marshall J; Cines M; Bennett D; Liittschwager EB
    J Am Coll Cardiol; 2000 Jan; 35(1):56-9. PubMed ID: 10636259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy.
    Gottlieb SS; Brater DC; Thomas I; Havranek E; Bourge R; Goldman S; Dyer F; Gomez M; Bennett D; Ticho B; Beckman E; Abraham WT
    Circulation; 2002 Mar; 105(11):1348-53. PubMed ID: 11901047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment.
    Dittrich HC; Gupta DK; Hack TC; Dowling T; Callahan J; Thomson S
    J Card Fail; 2007 Oct; 13(8):609-17. PubMed ID: 17923351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylline for Patients Hospitalized with Acute Decompensated Heart Failure and Volume Overload to Assess Treatment Effect on Congestion and Renal Function).
    Voors AA; Dittrich HC; Massie BM; DeLucca P; Mansoor GA; Metra M; Cotter G; Weatherley BD; Ponikowski P; Teerlink JR; Cleland JG; O'Connor CM; Givertz MM
    J Am Coll Cardiol; 2011 May; 57(19):1899-907. PubMed ID: 21545947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of adenosine antagonism in the cardiorenal syndrome.
    Dohadwala MM; Givertz MM
    Cardiovasc Ther; 2008; 26(4):276-86. PubMed ID: 19035879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rolofylline: a selective adenosine 1 receptor antagonist for the treatment of heart failure.
    Slawsky MT; Givertz MM
    Expert Opin Pharmacother; 2009 Feb; 10(2):311-22. PubMed ID: 19236201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual A1/A2B Receptor Blockade Improves Cardiac and Renal Outcomes in a Rat Model of Heart Failure with Preserved Ejection Fraction.
    Tofovic SP; Salah EM; Smits GJ; Whalley ET; Ticho B; Deykin A; Jackson EK
    J Pharmacol Exp Ther; 2016 Feb; 356(2):333-40. PubMed ID: 26585572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of adenosine A1-receptor antagonists in congestive heart failure.
    Gottlieb SS
    Drugs; 2001; 61(10):1387-93. PubMed ID: 11558828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A1 receptor antagonists in clinical research and development.
    Hocher B
    Kidney Int; 2010 Sep; 78(5):438-45. PubMed ID: 20592713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A1 receptor antagonists and the kidney.
    Modlinger PS; Welch WJ
    Curr Opin Nephrol Hypertens; 2003 Sep; 12(5):497-502. PubMed ID: 12920396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An orally active adenosine A1 receptor antagonist, FK838, increases renal excretion and maintains glomerular filtration rate in furosemide-resistant rats.
    Schnackenberg CG; Merz E; Brooks DP
    Br J Pharmacol; 2003 Aug; 139(8):1383-8. PubMed ID: 12922924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
    Givertz MM; Massie BM; Fields TK; Pearson LL; Dittrich HC;
    J Am Coll Cardiol; 2007 Oct; 50(16):1551-60. PubMed ID: 17936154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study.
    Greenberg B; Thomas I; Banish D; Goldman S; Havranek E; Massie BM; Zhu Y; Ticho B; Abraham WT
    J Am Coll Cardiol; 2007 Aug; 50(7):600-6. PubMed ID: 17692744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function.
    Weatherley BD; Cotter G; Dittrich HC; DeLucca P; Mansoor GA; Bloomfield DM; Ponikowski P; O'Connor CM; Metra M; Massie BM;
    J Card Fail; 2010 Jan; 16(1):25-35. PubMed ID: 20123315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiorenal syndrome in heart failure: a cardiologist's perspective.
    Liu PP
    Can J Cardiol; 2008 Jul; 24 Suppl B(Suppl B):25B-9B. PubMed ID: 18629386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure.
    Massie BM; O'Connor CM; Metra M; Ponikowski P; Teerlink JR; Cotter G; Weatherley BD; Cleland JG; Givertz MM; Voors A; DeLucca P; Mansoor GA; Salerno CM; Bloomfield DM; Dittrich HC;
    N Engl J Med; 2010 Oct; 363(15):1419-28. PubMed ID: 20925544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Additive Tolvaptan vs. Increased Furosemide on Heart Failure With Diuretic Resistance and Renal Impairment　- Results From the K-STAR Study.
    Inomata T; Ikeda Y; Kida K; Shibagaki Y; Sato N; Kumagai Y; Shinagawa H; Ako J; Izumi T;
    Circ J; 2017 Dec; 82(1):159-167. PubMed ID: 28835586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.